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Abstract
Electropermeabilization is a promising nonviral method for gene therapy. However, despite the fact that it is widely used to transfer genes
into living cells, the steps that limit DNA transfer remain to be determined. Here, we report the effect of cell synchronization on membrane
permeabilization and gene delivery by electric fields. Chinese hamster ovary (CHO) cells were synchronized by aphidicolin or butyrate
treatment. Electro-mediated transfection of these cells was evaluated under electric field conditions leading to the same level of membrane
permeabilization. Aphidicolin cell synchronization in G2/M phase leads to a slight increase in plasma membrane permeabilization but to a
three-fold increase in percentage of transfected cells and to an eight-fold increase in gene expression. This increase in cell transfection is
specifically due to the G2/M synchronization process. Indeed, cell synchronization in G1 phase by sodium butyrate has no effect on cell
permeabilization and transfection. Our results suggest that the enhanced transfection level in G2/M phase is not simply due to enhanced
permeabilization, but reinforce the statement that the melting of the nuclear membrane facilitates direct access of plasmid DNA to the
nucleus. D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Nonviral methods of gene delivery have been used in cell
transfection for years. These methods are chemical or
physical. Among physical methods, electropermeabilization,
also named electroporation (see Ref. [1] for review), a
method based on the application of electric field pulses to
cells, was developed in the early 1980s [2]. Electropermea-
bilization has been used with increasing popularity for
introducing DNA, proteins, metabolites and other small
molecules into a large variety of cell types growing both
in suspension or attached to surfaces [3–5]. Over the last 10
years, medical applications of this method have been
successfully developed, such as antitumoral drug delivery
to patients, a method called «electrochemotherapy» [6], and
transdermal drug delivery [7]. Electropermeabilization has
also been used for in vivo delivery of DNA into the skin,
liver, melanoma and skeletal muscle cells [8–11].
Different mechanisms of permeabilization and gene trans-
fer by electric fields have been reported in the literature [12–
17]. Electrotransfection has been described as a multistep
process. Plasmids have to be present during electropulsation
but cross the electropulsed membrane after pulse application
[18–21]. Indeed, we proposed a model in which only the
localized part of the cell membrane brought to the permea-
bilized state by the external field is competent for the transfer
[21]. It is a complex process, in which an anchoring step
connecting the plasmid to the electropermeabilized mem-
brane takes place during the pulse, followed by a post-pulse
transfer into the cytoplasm [20]. The plasmid has therefore to
be translocated through the membrane inside the cytoplasm.
Then, it has to reach the nucleus by crossing the nuclear
membrane for its expression. Membrane permeabilization is
necessary but not sufficient for an efficient gene transfer.
The nuclear envelope has been thought to be a critical
barrier for gene transfection. Indeed, in most cell types a
fundamental limitation to gene expression in currently used
nonviral systems seems to be the inability of DNA to
migrate from cytoplasm into the nucleus [22]. In G2/M
cycle phase, nuclear membrane disappeared and gene trans-
fection efficiency has been shown to be improved whatever
the gene transfer method used [23–25].
In the case of the electrically mediated gene transfer
method, the same result has been obtained. However, no
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study of the potential effect of the cell synchronization
process on cell permeabilization has been reported
[23,24,26,27]. Indeed, cell electrotransfection is strongly
dependent on cell electropermeabilization, which is corre-
lated to the cell diameter [2,21]. To go further into the
mechanism, the present study investigates the effect of cell
growth phase on gene electrotransfer at three levels: cell
size, plasma membrane permeabilization and gene expres-
sion.
2. Materials and methods
2.1. Cell culture and synchronization procedures
Chinese hamster ovary (CHO) cells were used. The WTT
clone was selected for its ability to grow in suspension or
plated on Petri dishes. They were grown as previously
described in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 8% foetal calf serum [28]. Their ability
to grow on a support after being maintained in suspension is
direct evidence of their viability.
Control cells were plated at a density of 5 106 cells per
flask (25 cm2, Nunc). After 24 h of culture, the density was
10 106 cells per flask.
For synchronization experiments, cells were plated at a
density of 10 106 cells per flask 2 h before synchroniza-
tion. G1 phase synchronization was performed by sodium
butyrate (10 mM) treatment added in culture medium during
24 h before experiments [29,30]. G2/M phase synchroniza-
tion was performed by aphidicolin (1 Ag/ml) treatment,
added in the culture medium for 20 h. Then, cells were
washed twice with PBS and re-fed with fresh medium to
stop the G1 phase blockage. Four hours later, cells were
synchronized in G2/M phase [27].
Before being processed for cell cycle analysis, cell diam-
eter determination, electropermeabilization and electrotrans-
fection, cells were washed twice with PBS and harvested by
trysinization and resuspended in the pulsation buffer.
2.2. Cell cycle analysis
Cells were permeabilized in lysophosphatidylcholine (1
mg/ml) containing pulsation buffer for 10 min. Permeabi-
lized cells were stained by propidium iodide (200 AM) and
analyzed for DNA contents by flow cytometry (Becton
Dickinson FACScan). The percentage of cells in each cell
cycle phase was estimated by using the SFIT model in the
cellFIT software. Values represent meansF S.E. (n = 3).
2.3. Plasmid
A 4.7 kb plasmid (pEGFP-C1 from Clontech, Palo Alto,
CA) carrying the gene of the green fluorescent protein
controlled by the CMV promoter was used. It was prepared
from transfected Escherichia coli cells by using the Max-
iprep DNA purification system according to manufacturer’s
instructions (Qiagen, Chatsworth, CA).
2.4. Electropulsation apparatus
Electropulsation was operated by using a CNRS cell
electropulsator (Jouan, St. Herblain, France), which deliv-
ered square-wave electric pulses. An oscilloscope (Enertec,
St. Etienne, France) monitored pulse shape. Two stainless-
steel flat parallel electrodes, connected to the voltage gen-
erator, gave a uniform electric field. The distance between
the electrodes was 5 mm.
2.5. Electropermeabilization procedures
Penetration of propidium iodide (100 AM) in low ionic
strength pulsation buffer (10 mM phosphate, 1 mM MgCl2,
250 mM sucrose, pH 7.4) was used to monitor permeabi-
lization. Cells were centrifuged for 5 min at 120 g and
resuspended in the pulsing buffer. One hundred microliters
of the cell suspension (i.e. 106 cells) were poured between
the electrodes. Ten pulses lasting 5 ms at a frequency of 1
Hz were applied at a given electric field intensity at room
temperature. After pulsation, cells were left at 30 jC for 10
min for membrane resealing. Cells were analyzed by flow
cytometry (Becton Dickinson FACScan) to determine both
the percentage of fluorescent cells (i.e. the percentage of
permeabilized cells) and the level of fluorescence associated
with this permeabilization (i.e. the efficiency of permeabi-
lization). The percentage of permeabilization is determined
based on the total number of cells submitted to treatment.
2.6. Electrotransfection procedures
Cells were resuspended in pEGFP-C1 plasmid containing
pulsation buffer. For each assay, 100 Al of cell suspension
were used corresponding to 106 cells mixed with 4 Ag
plasmid. The number of copies per cell was 7.9 105. This
preparation was incubated for 5 min at 4 jC before pulsation.
Ten pulses lasting 5 ms at a frequency of 1 Hz were applied
at a given electric field intensity at room temperature. Then,
cells were incubated for 10 min at 30 jC [31]. They were
cultured in Petri dishes with 2 ml of culture medium for 24 h
at 37 jC in a 5% CO2 incubator. Only plated cells (i.e.
viable) were taken into account in the assay. Cells were
harvested by trypsinization and analyzed by flow cytometry
to evaluate both the percentage of fluorescent cells (i.e.
percentage of GFP transfected cells) and the mean level of
fluorescence associated with this transfection (i.e. the effi-
ciency of transfection). The percentage of transfection was
therefore determined relative to the viable cells.
2.7. Cell diameter determination
An acquisition card (DC20, MIRO, Germany) captured
frames from a video camera (SONY, Japan) connected to an
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inverted microscope with an X 63 objective (Leica DM
IRB, Germany). Cell diameter was obtained by directly
measuring the size of cells in suspension on the PC monitor.
The precision of the measurement is 0.1 Am. More than 30
cells were assayed per condition. Cell diameter is given as
meanF S.E.
2.8. Statistical analysis of the data
Each histogram is the meanF S.E. of three separate
experiments done in duplicate.
3. Results and discussion
3.1. Cell synchronization
The percentage of cells in G2/M phase was 20% in
control cells and reached 82% after aphidicolin treatment.
The percentage of cells synchronized in G1 phase was 62%
in control cell and 82% with butyrate treatment (Fig. 1).
These observations were in agreement with those reported
by others [32–34].
3.2. Cell permeabilization
Cell permeabilization by electric fields depends on the
cell size [35]. Any increase in cell size could be associated
with a more efficient permeabilization for a given electric
field intensity. It has indeed been shown that the electric
field modulated the membrane potential difference [2]. The
transmembrane potential difference induced by the electric
field, DVM, is a complex function of the specific conductiv-
ities g (k) of the membrane, the pulsing buffer and the
cytoplasm, the membrane thickness and the cell size. Thus,
DVM ¼ fgðkÞrEcosh ð1Þ
in which h designates the angle between the direction of the
normal to the membrane at the considered point on the cell
surface and the field direction, E the field intensity, r the
radius of the cell and f is a shape factor. DVM is not uniform
on the cell surface. It is maximum at the positions of the cell
facing the electrodes. When the resulting transmembrane
potential difference DV (i.e. the sum between the resting
value of cell membrane DVo and the electroinduced value
DVM) reaches threshold values closed to 250 mV, mem-
branes become permeable [36,37]. Electric membrane prop-
erties of aphidicolin synchronized cells have been studied
by Sukhorukov et al. [34]. They showed that electric
properties, i.e. g (k) function, were similar for asynchronous
and synchronous cell membranes. Slight DVo changes dur-
ing cell cycle have been reported in the case of Chinese
hamster lung cells [38]. It varied from  20 mV in G1 phase
to  29 mV in S and G2 phases. During mitotic division, it
was equal to  22 mV. Thus, these two parameters should
not dramatically influence DV. Moreover, DV is a function of
cell geometry: cell shape and size. As cells in suspension
were used in this study, their shape was considered to be a
sphere and f remained 1.5 in all conditions. Thus, cell
permeabilization depends on the cell radius. The effect of
cell synchronization on permeabilization efficiency was
checked in this study.
CHO cells in suspension are spherical with a mean
diameter of 13.5F 1.4 Am. The mean diameter of synchron-
ized cells in G1 phase, equal to 12.6F 1.35 Am, was not
significantly different from control cells (P= 0.01). After
the aphidicolin treatment, cells synchronized in G2/M phase
significantly increased in size, their diameter reaching
Fig. 1. Cell cycle histograms of CHO cells. (A) Control cells. (B)
Aphidicolin synchronized cells in G2/M. (C) Sodium butyrate synchronized
cells in G1 phase.
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16.3F 1.5 Am (P < 0.001). Indeed, in aphidicolin synchron-
ized cells, synthesis of proteins and lipids has been shown to
be still present while cell cycle was blocked [34]. These
syntheses led to an increase of cell volume, which is in
agreement with our observations.
Cells were pulsed under optimum conditions for gene
transfer. Ten pulses, lasting 5 ms, were applied. Under those
conditions, 60% of control cells were permeabilized at 0.8
kV/cm and 80% at 0.9 kV/cm (Fig. 2A). The associated
fluorescence intensity, related to the number of molecules
incorporated into the electropermeabilized cells (Fig. 2B),
increased with an increase in the electric field intensity. The
amount of electroloaded molecules in permeabilized cell
increased with the electric field intensity, in agreement with
previous results [39]. The percentage of permeabilized cells
and the permeabilization efficiency for cells synchronized in
G1 phase were slightly smaller than for control cells (Fig.
2A,B). Cells synchronized in G2/M phase exhibited a 1.4-
fold increase in the percentage of permeabilization at 0.8
kV/cm and a slight increase at 0.9 kV/cm (Fig. 2A). This
synchronization effect was more pronounced when fluores-
cence intensities were compared. Electropermeabilized cells
in G2/M phase exhibited a two-fold increase in fluorescence
intensity at 0.8 and 0.9 kV/cm (Fig. 2B). However, this
increase had to be associated with the fact that in G2/M
phase, cells had 4N instead of 2N chromosomes and there-
fore two times more sites for PI interaction [40].
Fig. 2. Effect of cell synchronization on permeabilization. Control cells (n),
aphidicolin synchronized cells (5) and sodium butyrate synchronized cells
(8) were submitted to 10 pulses of 5 ms duration in pulsing buffer
containing propidium iodide. Permeabilization was analyzed by flow
cytometry. It was determined based on total number of cells. (A) Percentage
of permeabilized cells. (B) Associated mean fluorescence level of the
permeabilized cells. Values represent meansF S.E. (n= 3).
Fig. 3. Effect of cell synchronization on gene transfer and viability. Control
cells (n), aphidicolin synchronized cells (5) and sodium butyrate
synchronized cells (8) are submitted to 10 pulses of 5 ms duration in
pulsing buffer containing the pEGFP-C1 plasmid. Transfection was
analyzed by flow cytometry 24 h after electric treatment. It was determined
based on viable cells. (A) Percentage of electrotransfected cells. (B)
Associated mean fluorescence level of GFP expressing cells. (C) Cell
viability. Cells were pulsed in the absence of DNA. Viability was assayed
by crystal violet staining 24 h after electric treatment. Values represent
meansF S.E. (n= 3).
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3.3. Cell transfection
Twenty percent of control cells were transfected at 0.8 kV/
cm and 30% at 0.9 kV/cm (Fig. 3A). The associated
fluorescence intensity, related to the number of GFP mole-
cules produced into the electrotransfected cells, i.e. trans-
fection efficiency, was assessed as well (Fig. 3B). It increased
with an increase in the electric field intensity, in agreement
with previous results [21,41]. Similar percentages of trans-
fected cells and transfection efficiency were obtained when
cells were synchronized in G1 phase (Fig. 3A,B). Cells (after
aphidicolin treatment) submitted to electric pulses when in
G2/M phase, exhibited a 3-fold increase in the percentage of
transfected cells at 0.8 kV/cm and a 2.5-fold increase at 0.9
kV/cm (Fig. 3A). This increase in transfection was empha-
sized as far as the transfection efficiency was concerned.
Cells in G2/M phase exhibited an 8-fold increase in gene
expression at 0.8 kV/cm and a 6.5-fold increase at 0.9 kV/cm
(Fig. 3B). These data, based on viable cells, are comparable
when expressed on total number of cells. Such an increase in
transfection efficiency cannot simply be due to the slight
increase in permeabilization. As shown in Fig. 2A, control
cells pulsed at 0.9 kV/cm and G2/M synchronized cells
pulsed at 0.8 kV/cm led to the same percentage of perme-
abilization, i.e. 86%. However, the percentages of transfected
cells and the transfection efficiencies were different (Fig.
3A,B). Indeed, electric field conditions leading to the same
permeabilization efficiency clearly lead to a significant
increase in transfection efficiency for cells in the G2/M
phase. Under such electric field conditions, viability of the
cells was kept constant at 70% at 0.8 kV/cm and 50% at 0.9
kV/cm in control and G2/M phase (Fig. 3C). Viability was
slightly preserved in G1 phase probably due to the slight
decrease of cell diameter in this phase.
4. Conclusion
The results reported in this work lead to the conclusion that
the G2/M phase is well suited for efficient transient trans-
fection by electric fields. Aphidicolin and sodium butyrate
synchronization methods gave different results, indicating
that the observed effect was not due to the synchronization
process by itself but to the fact that cells were in the G2/M
phase when pulsed. This cell cycle dependence has already
been observed by others on human and mouse fibroblasts
[24,27], on K562 cells [32], B cells [33] and on human en-
dothelial cells [23] using electroporation transfection meth-
od. The reason for this cell cycle dependency was sug-
gested to be due to the loss of the nuclear membrane in
the M phase [23,24,27]. However, in these experiments, the
same electric field intensity was applied whatever the phase
of the cell cycle. Therefore, the potential effect of cell
synchronization on cell size and its consequence on cell
permeabilization and transfection were not checked. This
could explain why in the case of hematopoietic cells, the S-
phase was associated with an increase in gene expression
[26].
Another conclusion of the present work deals with the
lifetime of the plasmid in the cytoplasm. In 24 h, one cell
cycle has been performed; each cell has therefore reached the
G2/M phase in which plasmid DNA can cross the nuclear
envelope and can be expressed. Therefore, transfection
levels should be the same for control and synchronized cells.
However, our results showed that the transfection level of
G2/M synchronized cells was greater than the transfection
level of G1 synchronized cells. Thus, the plasmid could
reach the nucleus after electropulsation preferentially in G2/
M when the nuclear envelope was no longer present. Later,
most plasmids were probably degraded or no longer efficient
to transfect cells. This agrees with Lechardeur’s work
showing that naked plasmid DNA has a rapid turnover (t1/2
of 90 min) in the cytoplasm [42] and with our previous work
showing that a key step for gene expression after transfer by
electric field is present during the first 3 h following electric
pulse application [17]. Plasmid DNA crosses the nuclear
envelope with a very low efficiency. Mitosis considerably
enhances expression of the transgene as already observed
with cationic lipid-mediated gene transfer method [25].
In summary, our results showed that DNA expression in
cells was really enhanced in G2/M phase synchronized cells.
A more efficient permeabilization due to the increase of the
cell diameter in this phase could not explain this enhance-
ment. Late G2 or early M phase is thought to be associated
with the melting of the nuclear membrane that facilitates the
access of DNA to the transcription machinery. This could
contribute to the enhanced transcriptional activity of transi-
ently transfected expressing vectors. During cell electro-
transfection, the plasmid has to reach the nucleus once
inside the cytoplasm. Plasma membrane is the first barrier
for gene transfer. The present study reinforces the idea that the
nuclear membrane is a second barrier and therefore a limiting
step to cell transfection.
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